Progression of human breast cancers to the metastatic state is linked to genotypes of catechol-O-methyltransferase

Cancer Letters

Volumn 150, Issue 1, 2000, Pages 23-31

  Matsui, Akira ^a   Ikeda, Tadashi ^b   Enomoto, Kohji ^b   Nakashima, Hiroshi ^b   Omae, Kazuyuki ^b   Watanabe, Mamoru ^a   Hibi, Toshifumi ^a   Kitajima, Masaki ^b  

^a Keio Caner Center   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast cancer; Catechol O methyltransferase; Lymph node metastasis

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CATECHOL ESTROGEN; CATECHOL METHYLTRANSFERASE; ESTROGEN; GLUTATHIONE TRANSFERASE;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER STAGING; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GERM LINE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; DISEASE PROGRESSION; FEMALE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MIDDLE AGED; NEOPLASM METASTASIS; POLYMORPHISM, GENETIC;

EID: 0034047067     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00368-7     Document Type: Article

References (35)

1. Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Toutigian S., Liu Q., Cochran C., Bennett L.M., Ding W. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71.
2. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., Collins N., Gregory S., Gumbs C., Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature. 378:1995;789-792.
3. Colditz G.A. Hormone replacement therapy increases the risk of breast cancer. Ann. NY Acad. Sci. 833:1997;129-136.
4. Feigelson H.S., Henderson B.E. Estrogens and breast cancer. Carcinogenesis. 17:1996;2279-2284.
5. Zhu B.T., Conney A.H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis. 19:1998;1-27.
6. Service R.F. New role for estrogen in cancer? Science. 279:1998;1631-1633.
7. Akanni A., Abul-Hajj Y.J. Estrogen-nucleic acid adducts: reaction of 3,4-estrone-O-quinone radical anion with deoxyribonucleosides. Chem. Res. Toxicol. 10:1997;760-766.
8. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivedy I., Higginbothan S., Johansson S.L., Patil K.D., Gross M.L., Gooden J.K. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA. 94:1997;10937-10942.
9. Schutze N., Vollmer G., Knuppen R. Catecholestrogens are agonists of estrogen receptor dependent gene expression in MCF-7 cells. J. Steroid Biochem. Mol. Biol. 48:1994;453-461.
10. Schutze N., Vollmer G., Tiemann I., Geiger M., Knuppen R. Catecholestrogens are MCF-7 cell estrogen receptor agonists. J. Steroid Biochem. Mol. Biol. 46:1993;781-789.
11. Yoshie Y., Ohshima H. Synergistic inductions of DNA strand breakage by catechol-estrogen and nitric oxide: implications for hormonal carcinogenesis. Free Radic. Biol. Med. 24:1998;341-348.
12. Butterworth M., Lau S.S., Monks T.J. Formation of catechol estrogen glutathione conjugates and gamma-glutamyl transpeptidase-dependent nephrotoxicity of 17beta-estradiol in the golden Syrian hamster. Carcinogenesis. 18:1997;561-567.
13. Han X., Liehr J.G. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogenesis. 16:1995;2571-2574.
14. Lavigne J.A., Helzlsouer K.J., Huang H.Y., Strickland P.T., Bell D.A., Selmin O., Watson M.A., Hoffman S., Comstock G.W., Yager J.D. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res. 57:1997;5493-5497.
15. Thompson P.A., Shields P.G., Freudenheim J.L., Stone A., Vena J.E., Marshall J.R., Graham S., Laughlin R., Nemoto T., Kadlubar F.F., Ambrosone C.B. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res. 58:1998;2107-2110.
16. Millikan R.C., Pittman G.S., Tse C.K., Duell E., Newman B., Savitz D., Moorman P.G., Boissy R.J., Bell D.A. Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis. 19:1998;1943-1947.
17. Helzlsouer K.J., Selmin O., Huang H.Y., Strickland P.T., Hoffman S., Alberg A.J., Watson M., Comstock G.W., Bell D. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer [see comments]. J. Natl. Cancer Inst. 90:1998;512-518.
18. Maugard C.M., Charrier J., Bignon Y.J. Allelic deletion at glutathione S-transferase M1 locus and its association with breast cancer susceptibility. Chem. Biol. Interact. 112:1998;365-375.
19. Ambrosone C.B., Freudenheim J.L., Graham S., Marshall J.R., Vena J.E., Brasure J.R., Laughlin R., Nemoto T., Michalek A.M., Harrington A. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res. 55:1995;3483-3485.
20. Bailey L.R., Roodi N., Verrier C.S., Yee C.J., Dupont W.D., Parl F.F. Breast cancer and CYP1A1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res. 58:1998;65-70.
21. McLeod H.L., Syvanen A.C., Githang'a J., Indalo A., Ismail D., Ulmanen I., Sludden J. Ethnic differences in catechol-O-methyltransferase pharmacogenetics: frequency of the codon 108/158 low activity allele is lower in Kenyan than Caucasian or South-west Asian individuals. Pharmacogenetics. 8:1998;195-199.
22. Huang Z., Fasco M.J., Figge H.L., Keyomarsi K., Kaminsky L.S. Expression of cytochromes P450 in human breast tissue and tumors. Drug Metab. Dispos. 24:1996;899-905.
23. Murray G.I., Taylor M.C., McFadyen M.C.E., McKay J.A., Greenlee W.F., Burke M.D., Melvin W.T. Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res. 57:1997;3026-3031.
24. Spink D.C., Spink B.C., Cao J.Q., DePasquale J.A., Pentecost B.T., Fasco M.J., Li Y., Sutter T.R. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis. 19:1998;291-298.
25. Kelley M.K., Engqvist-Goldstein A., Montali J.A., Wheatley J.B., Schmidt D.E. Jr., Kauvar L.M. Variability of glutathione S-transferase isoenzyme patterns in matched normal and cancer human breast tissue. Biochem. J. 304:1994;843-848.
26. Tenhunen J., Heikkila P., Alanko A., Heinonen E., Akkila J., Ulmanen I. Soluble and membrane-bound catechol-O-methyltransferase in normal and malignant mammary gland. Cancer Lett. 144:1999;75-84.
27. Esteller M., Corn P.G., Urena J.M., Gabrielson E., Baylin S.B., Herman J.G. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res. 58:1998;4515-4518.
28. Seegers J.C., Lottering M.L., Grobler C.J., Papendorp D.H., Habbersett R.C., Shou Y., Lehnert B.E. The mammalian metabolite, 2-methoxyestradiol, affects P53 levels and apoptosis induction in transformed cells but not in normal cells. J. Steroid Biochem. Mol. Biol. 62:1997;253-267.
29. Zhu B.T., Conney A.H. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res. 58:1998;2269-2277.
30. Strous R.D., Bark N., Parsia S.S., Volavka J., Lachman H.M. Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatr. Res. 69:1997;71-77.
31. Lachman H.M., Nolan K.A., Mohr P., Saito T., Volavka J. Association between catechol-O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. Am. J. Psychiatr. 155:1998;835-837.
32. Kunugi H., Nanko S., Ueki A., Otsuka E., Hattori M., Hoda F., Vallada H.P., Arranz M.J., Collier D.A. High and low activity alleles of catechol-O-methyltransferase gene: ethnic difference and possible association with Parkinson's disease. Neurosci. Lett. 221:1997;202-204.
33. Smigel K. Breast Cancer Prevention Trial shows major benefit, some risk [news]. J. Natl. Cancer Inst. 90:1998;647-648.
34. Gottwald M.D., Bainbridge J.L., Dowling G.A., Aminoff M.J., Alldredge B.K. New pharmacotherapy for Parkinson's disease. Ann. Pharmacother. 31:1997;1205-1217.
35. Nutt J.G. Catechol-O-methyltransferase inhibitors for treatment of Parkinson's disease. Lancet. 351:1998;1221-1222.